The United States represents the largest share of the neural control market, driven by its advanced healthcare infrastructure, strong research ecosystem, and significant investments in neurotechnology innovation. The country is witnessing growing adoption of brain-computer interfaces (BCIs), neuroprosthetics, and neural stimulation devices for the treatment of neurological disorders such as...